chr22-41125844-CTTTTGTTTCT-C
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001429.4(EP300):c.730-18_730-9delTTTGTTTCTT variant causes a intron change. The variant allele was found at a frequency of 0.0122 in 1,611,928 control chromosomes in the GnomAD database, including 1,413 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.041 ( 419 hom., cov: 31)
Exomes 𝑓: 0.0091 ( 994 hom. )
Consequence
EP300
NM_001429.4 intron
NM_001429.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.05
Publications
4 publications found
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]
EP300 Gene-Disease associations (from GenCC):
- Rubinstein-Taybi syndromeInheritance: AD Classification: DEFINITIVE Submitted by: Illumina
- Rubinstein-Taybi syndrome due to EP300 haploinsufficiencyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
- retinitis pigmentosaInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 22-41125844-CTTTTGTTTCT-C is Benign according to our data. Variant chr22-41125844-CTTTTGTTTCT-C is described in ClinVar as Benign. ClinVar VariationId is 93745.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.196 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001429.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EP300 | NM_001429.4 | MANE Select | c.730-18_730-9delTTTGTTTCTT | intron | N/A | NP_001420.2 | |||
| EP300 | NM_001362843.2 | c.730-18_730-9delTTTGTTTCTT | intron | N/A | NP_001349772.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| EP300 | ENST00000263253.9 | TSL:1 MANE Select | c.730-19_730-10delTTTTGTTTCT | intron | N/A | ENSP00000263253.7 | |||
| EP300 | ENST00000634860.1 | TSL:3 | n.-7_3delTTTTGTTTCT | non_coding_transcript_exon | Exon 1 of 2 | ||||
| EP300 | ENST00000715703.1 | c.730-19_730-10delTTTTGTTTCT | intron | N/A | ENSP00000520505.1 |
Frequencies
GnomAD3 genomes AF: 0.0410 AC: 6230AN: 152040Hom.: 418 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
6230
AN:
152040
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0261 AC: 6543AN: 250674 AF XY: 0.0225 show subpopulations
GnomAD2 exomes
AF:
AC:
6543
AN:
250674
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00915 AC: 13350AN: 1459770Hom.: 994 AF XY: 0.00878 AC XY: 6377AN XY: 726298 show subpopulations
GnomAD4 exome
AF:
AC:
13350
AN:
1459770
Hom.:
AF XY:
AC XY:
6377
AN XY:
726298
show subpopulations
African (AFR)
AF:
AC:
3773
AN:
33344
American (AMR)
AF:
AC:
335
AN:
44596
Ashkenazi Jewish (ASJ)
AF:
AC:
13
AN:
26112
East Asian (EAS)
AF:
AC:
7001
AN:
39630
South Asian (SAS)
AF:
AC:
646
AN:
86100
European-Finnish (FIN)
AF:
AC:
1
AN:
53398
Middle Eastern (MID)
AF:
AC:
43
AN:
5760
European-Non Finnish (NFE)
AF:
AC:
363
AN:
1110552
Other (OTH)
AF:
AC:
1175
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
539
1078
1616
2155
2694
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0410 AC: 6237AN: 152158Hom.: 419 Cov.: 31 AF XY: 0.0406 AC XY: 3019AN XY: 74392 show subpopulations
GnomAD4 genome
AF:
AC:
6237
AN:
152158
Hom.:
Cov.:
31
AF XY:
AC XY:
3019
AN XY:
74392
show subpopulations
African (AFR)
AF:
AC:
4750
AN:
41514
American (AMR)
AF:
AC:
221
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1066
AN:
5160
South Asian (SAS)
AF:
AC:
67
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
58
AN:
68000
Other (OTH)
AF:
AC:
71
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
254
509
763
1018
1272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
286
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jul 01, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Sep 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Rubinstein-Taybi syndrome due to CREBBP mutations Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.